Ladone Mary Kay

Insider profile

Ladone Mary Kay's trades of Kestra Medical Technologies Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
257.45
Quantity 19,475 +33.6%
Value US$2,987,394
Transaction date
Planned sale
Price
155.08
Quantity 2,051 -100.0%
Value US$318,069
Transaction date
Planned sale
Price
110.00
Quantity 2,278 -21.8%
Value US$250,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-10 2026-09-08 S Sale
10,028 -41.2%
135.39
US$66,316
10,028 -41.2% 135.39 US$66,316
2026-09-08 2026-09-08 PrS Proposed sale
86,637
166.80
US$4,431,965
86,637 166.80 US$4,431,965
2021-11-12 2021-11-11 PlS Planned sale
19,475 +33.6%
257.45
US$2,987,394
19,475 +33.6% 257.45 US$2,987,394
2021-11-10 2021-11-08 PlS Planned sale
2,051 -100.0%
155.08
US$318,069
2,051 -100.0% 155.08 US$318,069
2021-11-10 2021-11-08 PlS Planned sale
872 -100.0%
155.08
US$135,230
872 -100.0% 155.08 US$135,230
2020-07-02 2020-06-30 PlS Planned sale
2,278 -21.8%
110.00
US$250,580
2,278 -21.8% 110.00 US$250,580